Movement Alert｜INSILICO Rises 5.09% in Regular Trading, Announces Research Collaboration with Korean THPharm

Market Focus08-13 13:01

On August 13, INSILICO rose 5.09% in regular trading, trading at 48.32 HKD/share, with turnover of HKD 318 million. The rally was driven by the announcement of a new research collaboration with Korean firm THPharm, adding to the company's intensifying pace of commercial partnership deals.

The THPharm collaboration marks the latest in a series of partnership milestones. JPMorgan disclosed on August 7 that it acquired 1.83 million shares at an average price of HKD 43.61, raising its long position to 5.1%. Guotai Haitong Securities also initiated coverage with an Overweight rating and a target price of HKD 73.23, citing the company's leading position in AI-driven drug discovery with end-to-end capabilities. Additionally, the company's board is scheduled to convene on August 26 to review interim results for the first half of the year.

Within the Life Sciences Tools & Services sector, peer stocks showed broad strength, with GENSCRIPT BIO up 6.6%, PHARMARON up 5.38%, XTALPI up 2.62%, WUXI APPTEC up 2.56%, and WUXI BIO up 1.71%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190966125?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-13 13:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190966125","market":"hk","top_or_hot":-1,"title":"Movement Alert｜INSILICO Rises 5.09% in Regular Trading, Announces Research Collaboration with Korean THPharm","media":"Market Focus","content":"<p><p>On August 13, INSILICO rose 5.09% in regular trading, trading at 48.32 HKD/share, with turnover of HKD 318 million. The rally was driven by the announcement of a new research collaboration with Korean firm THPharm, adding to the company's intensifying pace of commercial partnership deals.</p><p>The THPharm collaboration marks the latest in a series of partnership milestones. JPMorgan disclosed on August 7 that it acquired 1.83 million shares at an average price of HKD 43.61, raising its long position to 5.1%. Guotai Haitong Securities also initiated coverage with an Overweight rating and a target price of HKD 73.23, citing the company's leading position in AI-driven drug discovery with end-to-end capabilities. Additionally, the company's board is scheduled to convene on August 26 to review interim results for the first half of the year.</p><p>Within the Life Sciences Tools & Services sector, peer stocks showed broad strength, with GENSCRIPT BIO up 6.6%, PHARMARON up 5.38%, XTALPI up 2.62%, WUXI APPTEC up 2.56%, and WUXI BIO up 1.71%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜INSILICO Rises 5.09% in Regular Trading, Announces Research Collaboration with Korean THPharm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜INSILICO Rises 5.09% in Regular Trading, Announces Research Collaboration with Korean THPharm\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-13 13:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 13, INSILICO rose 5.09% in regular trading, trading at 48.32 HKD/share, with turnover of HKD 318 million. The rally was driven by the announcement of a new research collaboration with Korean firm THPharm, adding to the company's intensifying pace of commercial partnership deals.</p><p>The THPharm collaboration marks the latest in a series of partnership milestones. JPMorgan disclosed on August 7 that it acquired 1.83 million shares at an average price of HKD 43.61, raising its long position to 5.1%. Guotai Haitong Securities also initiated coverage with an Overweight rating and a target price of HKD 73.23, citing the company's leading position in AI-driven drug discovery with end-to-end capabilities. Additionally, the company's board is scheduled to convene on August 26 to review interim results for the first half of the year.</p><p>Within the Life Sciences Tools & Services sector, peer stocks showed broad strength, with GENSCRIPT BIO up 6.6%, PHARMARON up 5.38%, XTALPI up 2.62%, WUXI APPTEC up 2.56%, and WUXI BIO up 1.71%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1190966125","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190966125","pubTimestamp":1786597274,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 13, INSILICO rose 5.09% in regular trading, trading at 48.32 HKD/share, with turnover of HKD 318 million. The rally was driven by the announcement of a new research collaboration with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"走势警报|INSILICO 常规交易上涨 5.09%，宣布与韩国 THPharm 开展研究合作","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On August 13, INSILICO rose 5.09% in regular trading, trading at 48.32 HKD/share, with turnover of HKD 318 million. The rally was driven by the announcement of a new research collaboration with Korean firm THPharm, adding to the company's intensifying pace of commercial partnership deals.The THPharm collaboration marks the latest in a series of partnership milestones. JPMorgan disclosed on August 7 that it acquired 1.83 million shares at an average price of HKD 43.61, raising its long position to 5.1%. Guotai Haitong Securities also initiated coverage with an Overweight rating and a target price of HKD 73.23, citing the company's leading position in AI-driven drug discovery with end-to-end capabilities. Additionally, the company's board is scheduled to convene on August 26 to review interim results for the first half of the year.Within the Life Sciences Tools & Services sector, peer stocks showed broad strength, with GENSCRIPT BIO up 6.6%, PHARMARON up 5.38%, XTALPI up 2.62%, WUXI APPTEC up 2.56%, and WUXI BIO up 1.71%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190966125","isCrawlerRequest":true}